ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumour-cell Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-39P9840
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Tumour cell Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Tumour-cell Vaccine Market Research Report 2025

Code: QYRE-Auto-39P9840
Report
July 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AVAX Technologies
Vaccinogen
Aduro BioTech
Regeneus
Biovest

Tumour-cell Vaccine Market Size

The global market for Tumour-cell Vaccine was valued at US$ 259 million in the year 2024 and is projected to reach a revised size of US$ 382 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Tumour-cell Vaccine Market

Tumour-cell Vaccine Market

Tumour-cell vaccines which contain tumour cells obtained from the patient following surgery are intended to prevent disease recurrence in patients who have received prior treatment.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tumour-cell Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumour-cell Vaccine.
The Tumour-cell Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumour-cell Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumour-cell Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tumour-cell Vaccine Market Report

Report Metric Details
Report Name Tumour-cell Vaccine Market
Accounted market size in year US$ 259 million
Forecasted market size in 2031 US$ 382 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • MVax
  • OncoVAX
  • BiovaxID
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AVAX Technologies, Vaccinogen, Biovest, Aduro BioTech, Regeneus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tumour-cell Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tumour-cell Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tumour-cell Vaccine Market growing?

Ans: The Tumour-cell Vaccine Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Tumour-cell Vaccine Market size in 2031?

Ans: The Tumour-cell Vaccine Market size in 2031 will be US$ 382 million.

Who are the main players in the Tumour-cell Vaccine Market report?

Ans: The main players in the Tumour-cell Vaccine Market are AVAX Technologies, Vaccinogen, Biovest, Aduro BioTech, Regeneus

What are the Application segmentation covered in the Tumour-cell Vaccine Market report?

Ans: The Applications covered in the Tumour-cell Vaccine Market report are Pediatrics, Adults

What are the Type segmentation covered in the Tumour-cell Vaccine Market report?

Ans: The Types covered in the Tumour-cell Vaccine Market report are MVax, OncoVAX, BiovaxID, Others

Recommended Reports

Vaccine Market Trends

Cancer & Cell Therapy

Immunology & Cell Therapy

1 Tumour-cell Vaccine Market Overview
1.1 Product Definition
1.2 Tumour-cell Vaccine by Type
1.2.1 Global Tumour-cell Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 MVax
1.2.3 OncoVAX
1.2.4 BiovaxID
1.2.5 Others
1.3 Tumour-cell Vaccine by Application
1.3.1 Global Tumour-cell Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Pediatrics
1.3.3 Adults
1.4 Global Tumour-cell Vaccine Market Size Estimates and Forecasts
1.4.1 Global Tumour-cell Vaccine Revenue 2020-2031
1.4.2 Global Tumour-cell Vaccine Sales 2020-2031
1.4.3 Global Tumour-cell Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tumour-cell Vaccine Market Competition by Manufacturers
2.1 Global Tumour-cell Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tumour-cell Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tumour-cell Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tumour-cell Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumour-cell Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumour-cell Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Tumour-cell Vaccine, Date of Enter into This Industry
2.8 Global Tumour-cell Vaccine Market Competitive Situation and Trends
2.8.1 Global Tumour-cell Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tumour-cell Vaccine Players Market Share by Revenue
2.8.3 Global Tumour-cell Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumour-cell Vaccine Market Scenario by Region
3.1 Global Tumour-cell Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tumour-cell Vaccine Sales by Region: 2020-2031
3.2.1 Global Tumour-cell Vaccine Sales by Region: 2020-2025
3.2.2 Global Tumour-cell Vaccine Sales by Region: 2026-2031
3.3 Global Tumour-cell Vaccine Revenue by Region: 2020-2031
3.3.1 Global Tumour-cell Vaccine Revenue by Region: 2020-2025
3.3.2 Global Tumour-cell Vaccine Revenue by Region: 2026-2031
3.4 North America Tumour-cell Vaccine Market Facts & Figures by Country
3.4.1 North America Tumour-cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tumour-cell Vaccine Sales by Country (2020-2031)
3.4.3 North America Tumour-cell Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumour-cell Vaccine Market Facts & Figures by Country
3.5.1 Europe Tumour-cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tumour-cell Vaccine Sales by Country (2020-2031)
3.5.3 Europe Tumour-cell Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumour-cell Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Tumour-cell Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tumour-cell Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Tumour-cell Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tumour-cell Vaccine Market Facts & Figures by Country
3.7.1 Latin America Tumour-cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tumour-cell Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Tumour-cell Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumour-cell Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumour-cell Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tumour-cell Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tumour-cell Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumour-cell Vaccine Sales by Type (2020-2031)
4.1.1 Global Tumour-cell Vaccine Sales by Type (2020-2025)
4.1.2 Global Tumour-cell Vaccine Sales by Type (2026-2031)
4.1.3 Global Tumour-cell Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Tumour-cell Vaccine Revenue by Type (2020-2031)
4.2.1 Global Tumour-cell Vaccine Revenue by Type (2020-2025)
4.2.2 Global Tumour-cell Vaccine Revenue by Type (2026-2031)
4.2.3 Global Tumour-cell Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Tumour-cell Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tumour-cell Vaccine Sales by Application (2020-2031)
5.1.1 Global Tumour-cell Vaccine Sales by Application (2020-2025)
5.1.2 Global Tumour-cell Vaccine Sales by Application (2026-2031)
5.1.3 Global Tumour-cell Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Tumour-cell Vaccine Revenue by Application (2020-2031)
5.2.1 Global Tumour-cell Vaccine Revenue by Application (2020-2025)
5.2.2 Global Tumour-cell Vaccine Revenue by Application (2026-2031)
5.2.3 Global Tumour-cell Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Tumour-cell Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AVAX Technologies
6.1.1 AVAX Technologies Company Information
6.1.2 AVAX Technologies Description and Business Overview
6.1.3 AVAX Technologies Tumour-cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AVAX Technologies Tumour-cell Vaccine Product Portfolio
6.1.5 AVAX Technologies Recent Developments/Updates
6.2 Vaccinogen
6.2.1 Vaccinogen Company Information
6.2.2 Vaccinogen Description and Business Overview
6.2.3 Vaccinogen Tumour-cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Vaccinogen Tumour-cell Vaccine Product Portfolio
6.2.5 Vaccinogen Recent Developments/Updates
6.3 Biovest
6.3.1 Biovest Company Information
6.3.2 Biovest Description and Business Overview
6.3.3 Biovest Tumour-cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biovest Tumour-cell Vaccine Product Portfolio
6.3.5 Biovest Recent Developments/Updates
6.4 Aduro BioTech
6.4.1 Aduro BioTech Company Information
6.4.2 Aduro BioTech Description and Business Overview
6.4.3 Aduro BioTech Tumour-cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aduro BioTech Tumour-cell Vaccine Product Portfolio
6.4.5 Aduro BioTech Recent Developments/Updates
6.5 Regeneus
6.5.1 Regeneus Company Information
6.5.2 Regeneus Description and Business Overview
6.5.3 Regeneus Tumour-cell Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Regeneus Tumour-cell Vaccine Product Portfolio
6.5.5 Regeneus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumour-cell Vaccine Industry Chain Analysis
7.2 Tumour-cell Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumour-cell Vaccine Production Mode & Process Analysis
7.4 Tumour-cell Vaccine Sales and Marketing
7.4.1 Tumour-cell Vaccine Sales Channels
7.4.2 Tumour-cell Vaccine Distributors
7.5 Tumour-cell Vaccine Customer Analysis
8 Tumour-cell Vaccine Market Dynamics
8.1 Tumour-cell Vaccine Industry Trends
8.2 Tumour-cell Vaccine Market Drivers
8.3 Tumour-cell Vaccine Market Challenges
8.4 Tumour-cell Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AVAX Technologies
Vaccinogen
Aduro BioTech
Regeneus
Biovest
List of Tables
 Table 1. Global Tumour-cell Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tumour-cell Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tumour-cell Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tumour-cell Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Tumour-cell Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tumour-cell Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tumour-cell Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tumour-cell Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tumour-cell Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tumour-cell Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tumour-cell Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Tumour-cell Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tumour-cell Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumour-cell Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tumour-cell Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tumour-cell Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Tumour-cell Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Tumour-cell Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Tumour-cell Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Tumour-cell Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tumour-cell Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Tumour-cell Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tumour-cell Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Tumour-cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tumour-cell Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Tumour-cell Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Tumour-cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tumour-cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tumour-cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tumour-cell Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Tumour-cell Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Tumour-cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tumour-cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tumour-cell Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tumour-cell Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Tumour-cell Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Tumour-cell Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tumour-cell Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tumour-cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tumour-cell Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Tumour-cell Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Tumour-cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tumour-cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tumour-cell Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tumour-cell Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Tumour-cell Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Tumour-cell Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tumour-cell Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tumour-cell Vaccine Sales (K Dose) by Type (2020-2025)
 Table 51. Global Tumour-cell Vaccine Sales (K Dose) by Type (2026-2031)
 Table 52. Global Tumour-cell Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Tumour-cell Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Tumour-cell Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tumour-cell Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tumour-cell Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Tumour-cell Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Tumour-cell Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Tumour-cell Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Tumour-cell Vaccine Sales (K Dose) by Application (2020-2025)
 Table 61. Global Tumour-cell Vaccine Sales (K Dose) by Application (2026-2031)
 Table 62. Global Tumour-cell Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Tumour-cell Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Tumour-cell Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tumour-cell Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tumour-cell Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Tumour-cell Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Tumour-cell Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Tumour-cell Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. AVAX Technologies Company Information
 Table 71. AVAX Technologies Description and Business Overview
 Table 72. AVAX Technologies Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. AVAX Technologies Tumour-cell Vaccine Product
 Table 74. AVAX Technologies Recent Developments/Updates
 Table 75. Vaccinogen Company Information
 Table 76. Vaccinogen Description and Business Overview
 Table 77. Vaccinogen Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Vaccinogen Tumour-cell Vaccine Product
 Table 79. Vaccinogen Recent Developments/Updates
 Table 80. Biovest Company Information
 Table 81. Biovest Description and Business Overview
 Table 82. Biovest Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Biovest Tumour-cell Vaccine Product
 Table 84. Biovest Recent Developments/Updates
 Table 85. Aduro BioTech Company Information
 Table 86. Aduro BioTech Description and Business Overview
 Table 87. Aduro BioTech Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Aduro BioTech Tumour-cell Vaccine Product
 Table 89. Aduro BioTech Recent Developments/Updates
 Table 90. Regeneus Company Information
 Table 91. Regeneus Description and Business Overview
 Table 92. Regeneus Tumour-cell Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Regeneus Tumour-cell Vaccine Product
 Table 94. Regeneus Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Tumour-cell Vaccine Distributors List
 Table 98. Tumour-cell Vaccine Customers List
 Table 99. Tumour-cell Vaccine Market Trends
 Table 100. Tumour-cell Vaccine Market Drivers
 Table 101. Tumour-cell Vaccine Market Challenges
 Table 102. Tumour-cell Vaccine Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tumour-cell Vaccine
 Figure 2. Global Tumour-cell Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tumour-cell Vaccine Market Share by Type: 2024 & 2031
 Figure 4. MVax Product Picture
 Figure 5. OncoVAX Product Picture
 Figure 6. BiovaxID Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Tumour-cell Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Tumour-cell Vaccine Market Share by Application: 2024 & 2031
 Figure 10. Pediatrics
 Figure 11. Adults
 Figure 12. Global Tumour-cell Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Tumour-cell Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Tumour-cell Vaccine Sales (2020-2031) & (K Dose)
 Figure 15. Global Tumour-cell Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 16. Tumour-cell Vaccine Report Years Considered
 Figure 17. Tumour-cell Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Tumour-cell Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Tumour-cell Vaccine Players: Market Share by Revenue in Tumour-cell Vaccine in 2024
 Figure 20. Tumour-cell Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Tumour-cell Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Tumour-cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Tumour-cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Tumour-cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Tumour-cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Tumour-cell Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Tumour-cell Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Tumour-cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Tumour-cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Tumour-cell Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Tumour-cell Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Tumour-cell Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Tumour-cell Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Tumour-cell Vaccine by Type (2020-2031)
 Figure 56. Global Tumour-cell Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Tumour-cell Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Tumour-cell Vaccine by Application (2020-2031)
 Figure 59. Global Tumour-cell Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 60. Tumour-cell Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dendritic Cell Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Adjuvants Market Insights Forecast to 2030
Global Animal Vaccines Market Insights Forecast to 2030
Global Dendritic Cell Vaccine Market Research Report 2025
Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
SARS Cov 2 Vaccine Vero Cell Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Combination Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Emerging Cancer Vaccines Market Insights Forecast to 2030
Neoantigen Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Immunity Therapy Market Research Report 2024
4 valent HPV Vaccine 4vHPV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tumor Blood Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Regeneration Medicine Market Research Report 2024
Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions